Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Cayman Islands.
Press releases published on June 2, 2025
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
GlobeNewswire
·
June 2, 2025
Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
GlobeNewswire
·
June 2, 2025
Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications …
FansHash Empowers Global Investors with Daily Passive Income via Cloud Mining
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As Bitcoin approaches its all-time high, Fanshash’s user-friendly, maintenance-free cloud mining platform has attracted a surge of miners, gaining significant momentum. Amid the latest crypto market rally, …
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
– CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients – – Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, or FLT3 …
MDB Capital Holdings Announces Transitions In Its Board of Directors
GlobeNewswire
·
June 2, 2025
Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board …
SunnyMining Gains Institutional Interest as Cloud Mining Sees Accelerated Adoption
GlobeNewswire
·
June 2, 2025
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows that as the popularity of cryptocurrencies continues to rise, an increasing number of users from platforms like Coinbase and Kraken are turning to cloud mining. …
Cloud Mining in 2025: How VNBTC Is Reshaping Free Crypto Income Opportunities Globally
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As cloud mining becomes one of the fastest-growing passive income methods in the digital asset space, VNBTC, a free cloud mining platform, is rapidly gaining global recognition for making free cloud mining both …
Altai Announces Repositioning of Investment Portfolio to Maximize Liquidity
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Company has completed the repositioning of its Canadian investment portfolio (the “Investment Portfolio”) through the sale of …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s 2025 …
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 2, 2025
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 2, 2025
Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025 Leading Independent Proxy Advisory Firms, ISS and Glass …
Turtle Beach Corporation to Participate in Fireside Chat Hosted by Maxim Group
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today announced that Cris Keirn, Chief Executive Officer, and Mark Weinswig, Chief Financial Officer, will participate in a fireside …
Sernova Appoints Jonathan Rigby as Interim Chair
GlobeNewswire
·
June 2, 2025
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 …
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025
GlobeNewswire
·
June 2, 2025
– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonstrated 40% objective response rate – – The trial evaluated three doses of onvansertib in combination with paclitaxel, and …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 30, 2025, the company issued inducement awards to …
Abivax Presents First Quarter 2025 Financial Results
GlobeNewswire
·
June 2, 2025
Abivax Presents First Quarter 2025 Financial Results PARIS, France, June 2, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Best Bitcoin (BTC) Cloud Mining Option in 2025: Earn Mining Stands Out
GlobeNewswire
·
June 2, 2025
Miami, Florida, United States, June 02, 2025 (GLOBE NEWSWIRE) -- With the continuous advancement of artificial intelligence and the continued rise of the cryptocurrency market, cloud mining is accelerating towards efficiency, intelligence and …